Relevant bibliographies by topics / Concerta / Journal articles
To see the other types of publications on this topic, follow the link: Concerta.

Journal articles on the topic 'Concerta'

Author: Grafiati
Published: 4 June 2021
Last updated: 1 February 2022

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Concerta.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Ciccone, Patrick E. "ATTEMPTED ABUSE OF CONCERTA." Journal of the American Academy of Child & Adolescent Psychiatry 41, no. 7 (July 2002): 756. http://dx.doi.org/10.1097/00004583-200207000-00002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Millichap, J. Gordon. "Priapism Associated with MethylphenidateSR (Concerta) Withdrawal." Pediatric Neurology Briefs 18, no. 7 (July 1, 2004): 51. http://dx.doi.org/10.15844/pedneurbriefs-18-7-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

FINN, ROBERT. "Small CV Changes Seen With Concerta." Family Practice News 39, no. 21 (December 2009): 41. http://dx.doi.org/10.1016/s0300-7073(10)70203-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Finn, Robert. "Concerta Effective For ADHD in Teens." Internal Medicine News 38, no. 15 (August 2005): 39. http://dx.doi.org/10.1016/s1097-8690(05)71267-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Millichap, J. Gordon. "Concerta cf Ritalin Effects on Driving Performance." Pediatric Neurology Briefs 18, no. 3 (March 1, 2004): 22. http://dx.doi.org/10.15844/pedneurbriefs-18-3-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

LEVENSON, DEBORAH. "FDA Panel Delays Changes to Concerta Label." Clinical Psychiatry News 33, no. 8 (August 2005): 10. http://dx.doi.org/10.1016/s0270-6644(05)70573-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Lally, Michelle D., Mary C. Kral, and Andrea D. Boan. "Not All Generic Concerta Is Created Equal." Clinical Pediatrics 55, no. 13 (July 21, 2016): 1197–201. http://dx.doi.org/10.1177/0009922815611647.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

MCNAMARA, DAMIAN, and MIAMI BUREAU. "Concerta 72 mg, Allegra-D 24 Hour." Family Practice News 35, no. 1 (January 2005): 38. http://dx.doi.org/10.1016/s0300-7073(05)70475-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Jaffe, Steven L. "FAILED ATTEMPTS AT INTRANASAL ABUSE OF CONCERTA." Journal of the American Academy of Child & Adolescent Psychiatry 41, no. 1 (January 2002): 5. http://dx.doi.org/10.1097/00004583-200201000-00003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Innes, Carmen. "Once-daily 'Concerta' attention-grabbing in ADHD." Inpharma Weekly &NA;, no. 1241 (June 2000): 9. http://dx.doi.org/10.2165/00128413-200012410-00017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

LEVENSON, DEBORAH. "FDA Panel: Delay Safety Changes to Concerta Label." Pediatric News 39, no. 8 (August 2005): 1–8. http://dx.doi.org/10.1016/s0031-398x(05)70469-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

Kola, V. P. "2638 – Successful treatment of narcolepsy with methylphenidate (concerta)." European Psychiatry 28 (January 2013): 1. http://dx.doi.org/10.1016/s0924-9338(13)77271-7.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

BRUNK, DOUG. "Concerta Effective for ADHD Plus Epilepsy in Small Study." Clinical Psychiatry News 34, no. 12 (December 2006): 30. http://dx.doi.org/10.1016/s0270-6644(06)71971-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

BRUNK, DOUG. "Concerta May Benefit Children Who Have ADHD Plus Epilepsy." Pediatric News 40, no. 12 (December 2006): 25. http://dx.doi.org/10.1016/s0031-398x(06)71540-5.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

FINN, ROBERT. "Double-Blind Study Shows Concerta Effective Against ADHD in Teens." Pediatric News 39, no. 8 (August 2005): 28. http://dx.doi.org/10.1016/s0031-398x(05)70505-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Ozdemir, Esra, Mehmet Goksin Karaman, Nihal Yurteri, and Ayten Erdogan. "A case of suicide attempt with long-acting methylphenidate (Concerta)." ADHD Attention Deficit and Hyperactivity Disorders 2, no. 3 (May 25, 2010): 103–5. http://dx.doi.org/10.1007/s12402-010-0026-y.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Stefanija, Leon. "Concerto abbreviato Petra Bergama (1966)." Musicological Annual 51, no. 1 (June 1, 2015): 161–66. http://dx.doi.org/10.4312/mz.51.1.161-166.

Full text
Abstract:
Prispevek se ukvarja z kompozicijskimi in estetskimi potezami Concerta abbreviataza solo klarinet iz leta 1966 Petra Bergama. Zgodovinski kontekst in eksplicitna glasbena poetika skladatelja sta dopolnjena s stališči recepcijske zgodovine dela. Analiza oblikovnosti skladbe je podana v obliki pragmatičnih (fenomenoloških) komentarjev procesa strukturiranja celote. Izsledki analize opredeljujejo vrsto trenj med avantgardnimi in tradicionalistični mi značilnostmi in umeščajo skladbo med vredne primere musique informelleobdobja, ko so se glasbene avantgarde razvejale na vrsto tokov.
APA, Harvard, Vancouver, ISO, and other styles
18

Ellis, Chris. "Ethical issues with cognitive enhancement." South African Family Practice 59, no. 3 (March 28, 2017): 59. http://dx.doi.org/10.4102/safp.v59i3.4672.

Full text
Abstract:
Over the last few years I have had a small but steady number of normal students asking for stimulants such as methylphenidate (Ritalin, Concerta) to help them with their studying and exams. This may partly be because my rooms are near our local university campus.
APA, Harvard, Vancouver, ISO, and other styles
19

Pelham, W. E., E. M. Gnagy, L. Burrows-Maclean, A. Williams, G. A. Fabiano, S. M. Morrisey, A. M. Chronis, et al. "Once-a-Day Concerta Methylphenidate Versus Three-Times-Daily Methylphenidate in Laboratory and Natural Settings." PEDIATRICS 107, no. 6 (June 1, 2001): e105-e105. http://dx.doi.org/10.1542/peds.107.6.e105.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

SANDLER, ADRIAN D. "Once-a-day Concerta methylphenidate versus three-times-daily methylphenidate in laboratory and natural settings." Journal of Developmental & Behavioral Pediatrics 22, no. 6 (December 2001): 449. http://dx.doi.org/10.1097/00004703-200112000-00022.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Katzman, Martin A., and Tia Sternat. "A Review of OROS Methylphenidate (Concerta®) in the Treatment of Attention-Deficit/Hyperactivity Disorder." CNS Drugs 28, no. 11 (August 14, 2014): 1005–33. http://dx.doi.org/10.1007/s40263-014-0175-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
22

Connor, D. "Once a day Concerta methylphenidate was equivalent to 3 times daily methylphenidate in children with ADHD." Evidence-Based Mental Health 5, no. 1 (February 1, 2002): 20. http://dx.doi.org/10.1136/ebmh.5.1.20.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Auiler, Joanna F., Joseph M. Lynch, and Cathy K. Gelotte. "Reply to comments by Gonzalez et al. on the Concerta, Adderall XR Food Evaluation (CAFE) Study." Current Medical Research and Opinion 19, no. 1 (January 2003): 64–65. http://dx.doi.org/10.1185/030079902125001470.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Spencer, Thomas J., Eric Mick, Craig B. H. Surman, Paul Hammerness, Robert Doyle, Megan Aleardi, Meghan Kotarski, Courtney G. Williams, and Joseph Biederman. "A Randomized, Single-Blind, Substitution Study of OROS Methylphenidate (Concerta) in ADHD Adults Receiving Immediate Release Methylphenidate." Journal of Attention Disorders 15, no. 4 (May 21, 2010): 286–94. http://dx.doi.org/10.1177/1087054710367880.

Full text
APA, Harvard, Vancouver, ISO, and other styles
25

Swanson, J. M., M. Lerner, T. Wigal, K. Steinhoff, L. Greenhill, K. Posner, J. Freid, and S. Wigal. "The use of a laboratory school protocol to evaluate concepts about efficacy and side effects of new formulations of stimulant medications." Journal of Attention Disorders 6, no. 1_suppl (April 2002): 73–88. http://dx.doi.org/10.1177/070674370200601s10.

Full text
Abstract:
Recently, new long-acting formulations of racemic methylphenidate (MPH: Ritalin® LA, Metadate® CD and Concerta®) and amphetamine (AMP: Adderall XR®) were developed and are now approved by the Food and Drug Administration (FDA). In addition, dexmethylphenidate (Focalin ™), the pharmacologically active d-threo enantiomer of MPH, also was approved by the FDA. In the initial phases of development, prototypes of these five new formulations were evaluated using the University of California, Irvine (UCI) Laboratory School Protocol (LSP), in which surrogate measures of efficacy are collected in highly controlled settings rather than clinical measures of effectiveness in the less-controlled, natural environments of home or school. The LSP studies were followed by large effectiveness and safety studies required for gaining FDA approval. These initial efficacy and side effect studies in the LSP provided missing information about the basic pharmacokinetic (PK) and pharmacodynamic (PD) properties of MPH and AMP and produced some new discoveries (i.e., acute tolerance) that were used to help design the final products. The final once-a-day formulations used different drug delivery systems to achieve long-acting efficacy (Ritalin® LA, Metadate® CD, Concerta®, Adderall XR®). All four drug delivery systems were based on two processes: first, a bolus delivery (BD) process to achieve rapid onset of efficacy (mg), and second, a controlled delivery (CD) process to achieve rates of delivery (mg/hr) or a delayed bolus (mg) to maintain efficacy. A theoretical approach was used to compare and contrast the new once-a day formulations of MPH by selecting total daily doses (mg/d) that would equate drug delivery by the first process (mg of the Initial bolus) and the second process (mg/hr over specified time period). In addition to efficacy, applications of the LSP to measure common side effects related to eating and sleeping were described and discussed.
APA, Harvard, Vancouver, ISO, and other styles
26

Toassa, Gisele. "Sociedade Tarja Preta: uma crítica à medicalização de crianças e adolescentes." Fractal : Revista de Psicologia 24, no. 2 (August 2012): 429–34. http://dx.doi.org/10.1590/s1984-02922012000200015.

Full text
Abstract:
Como breve análise do livro "Medicalização de crianças e adolescentes: conflitos silenciados pela redução de questões sociais a doenças de indivíduos", esta resenha contextualiza a importância da publicação na crítica contemporânea à invenção de (psico)patologias e tratamentos a elas destinados. O livro logra, de forma extremamente rigorosa, desconstruir as "bases científicas" que sustentam o transtorno de déficit de atenção e hiperatividade (TDAH), mostrando como a indústria farmacêutica vem ocultando sistematicamente os profundos efeitos colaterais do princípio ativo destinado a tratá-lo (o metilfenidato, presente na Ritalina® e Concerta®). Com textos de profissionais vinculados à saúde e educação, nas mais diferentes áreas do conhecimento, o livro representa uma notável coalizão de esforços em benefício da promoção dos direitos de crianças e adolescentes.
APA, Harvard, Vancouver, ISO, and other styles
27

Cortez, Marilene tavares, and Denise Carneiro dos Reis Bernardo. "A JUDICIALIZAÇÃO DO TRANSTORNO DE DÉFICIT DE ATENÇÃO E HIPERATIVIDADE E A ONERAÇÃO DO ERÁRIO PÚBLICO." RAHIS- Revista de Administração Hospitalar e Inovação em Saúde 15, no. 3 (March 28, 2019): 31–47. http://dx.doi.org/10.21450/rahis.v15i3.5156.

Full text
Abstract:
As demandas judiciais por medicamentos não dispensados pelo Sistema Única de Saúde (SUS) geram consequências orçamentárias preocupantes, pois os recursos são limitados e seu gerenciamento deve ser executado segundo as normas das políticas de saúde. Um dos medicamentos mais solicitados judicialmente para a população infanto-juvenil diagnostica com o Transtorno de Déficit de Atenção e Hiperatividade (TDAH) é o metilfenidato, princípio ativo da Ritalina e do Concerta. Neste contexto, o objetivo geral do trabalho foi investigar a relação entre diagnóstico, judicialização do TDAH e possível oneração do erário público com a prescrição desse medicamento. Para alcançar o objetivo proposto, a pesquisa envolveu investigação quali-quantitativa. Os achados evidenciaram a oneração dos cofres públicos com a judicialização do TDAH e a presença de diagnósticos falso-positivos na amostra.
APA, Harvard, Vancouver, ISO, and other styles
28

Chang, Cheng-Hsi, Cheng-Fan Yang, Ying-Che Huang, Gau-Jun Tang, Kwok-Han Chan, and Chien-Kun Ting. "General Anesthesia in a Juvenile With Attention-deficit Hyperactivity Disorder Accompanied by Long-term Use of Methylphenidate (Concerta®)." Acta Anaesthesiologica Taiwanica 47, no. 4 (December 2009): 208–11. http://dx.doi.org/10.1016/s1875-4597(09)60057-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

&NA;. "Health Canada has approved a new formulation of methylphenidate ['Concerta'; Janssen-Ortho Inc.] for use in children with ADHD." Inpharma Weekly &NA;, no. 1398 (August 2003): 21. http://dx.doi.org/10.2165/00128413-200313980-00049.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Rizkallah, Élie, Louis Legault, Tania Pampoulova, Sylvie Lévesque, Michèle Bélanger, Katherine Stavro, Jean-Pierre Chiasson, and Stéphane Potvin. "A Case Report of Concerta Misuse in a Patient with Comorbid Substance Use Disorder and Attention Deficit Hyperactivity Disorder." American Journal on Addictions 20, no. 5 (July 18, 2011): 478–79. http://dx.doi.org/10.1111/j.1521-0391.2011.00158.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Klampfl, K., A. Quattländer, R. Burger, B. Pfuhlmann, A. Warnke, and M. Gerlach. "Case report: intoxication with high dose of long-acting methylphenidate (Concerta®) in a suicidal 14-year-old girl." ADHD Attention Deficit and Hyperactivity Disorders 2, no. 4 (September 14, 2010): 221–24. http://dx.doi.org/10.1007/s12402-010-0032-0.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

Imbert, Bruce, Nathalie Labrune, Christophe Lancon, and Nicolas Simon. "Use of Extended-Release Methylphenidate (Concerta) in Treatment of Cocaine Dependence in a Patient Presenting With Attention Deficit Hyperactivity Disorder." Journal of Neuropsychiatry and Clinical Neurosciences 26, no. 3 (January 2014): E49—E50. http://dx.doi.org/10.1176/appi.neuropsych.13080194.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Fife, Daniel, M. Soledad Cepeda, Alan Baseman, Henry Richards, Peter Hu, H. Lynn Starr, and Anthony G. Sena. "Medication changes after switching from CONCERTA® brand methylphenidate HCl to a generic long-acting formulation: A retrospective database study." PLOS ONE 13, no. 2 (February 28, 2018): e0193453. http://dx.doi.org/10.1371/journal.pone.0193453.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Lapinsky, David J., Ranganadh Velagaleti, Nageswari Yarravarapu, Yi Liu, Yurong Huang, Christopher K. Surratt, John R. Lever, et al. "Azido-iodo-N-benzyl derivatives of threo-methylphenidate (Ritalin, Concerta): Rational design, synthesis, pharmacological evaluation, and dopamine transporter photoaffinity labeling." Bioorganic & Medicinal Chemistry 19, no. 1 (January 2011): 504–12. http://dx.doi.org/10.1016/j.bmc.2010.11.002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Trigueiro, Emilia Suitberta de Oliveira. "A medicalização social e o uso do metilfenidato no aprimoramento cognitivo farmacológico." Research, Society and Development 9, no. 7 (May 17, 2020): e379974301. http://dx.doi.org/10.33448/rsd-v9i7.4301.

Full text
Abstract:
O uso de medicamentos, por pessoas saudáveis, para melhorar o funcionamento do cérebro e aprimorar o desempenho cognitivo pode ser chamado de aprimoramento cognitivo farmacológico ou de doping intelectual. Um dos medicamentos mais utilizados no Brasil com esta finalidade é o Cloridrato de Metilfenidato, comercializado com o nome de Ritalina ou Concerta. O presente artigo objetivou compreender, por meio de uma revisão de literatura, como o cloridrato metilfenidato tem sido utilizado no aprimoramento cognitivo farmacológico e a relação deste fenômeno com a medicalização social. Sabe-se que estes medicamentos tem como efeito imediato o aumento da concentração, mas a longo prazo podem causar supressão do crescimento, aumento da pressão sanguínea, episódios psicóticos, entre outros. Ainda assim, eles tem sido utilizados por estudantes universitários com a finalidade de aumentar sua capacidade produtiva e cumprir prazos e metas. Como esta prática tem ganhado cada vez mais adeptos e o acesso a este medicamento é facilitado, é necessário aprofundar o entendimento deste fenômeno.
APA, Harvard, Vancouver, ISO, and other styles
36

Fallu, Angelo, Farida Dabouz, Melissa Furtado, Leena Anand, and Martin A. Katzman. "A randomized, double-blind, cross-over, phase IV trial of oros-methylphenidate (CONCERTA®) and generic novo-methylphenidate ER-C (NOVO-generic)." Therapeutic Advances in Psychopharmacology 6, no. 4 (July 31, 2016): 237–51. http://dx.doi.org/10.1177/2045125316643674.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Revenko, Natalia. "Ukrainian piano concert in the repertoire of the future teacher of music art." Scientific Visnyk V.O. Sukhomlynskyi Mykolaiv National University. Pedagogical Sciences 66, no. 3 (2019): 191–95. http://dx.doi.org/10.33310/2518-7813-2019-66-3-191-195.

Full text
Abstract:
The article highlights the methods of working on a Ukrainian piano concert with students-pianists in the lessons on "Instrumental Performance (Piano)" in higher education institutions. The stages of the formation and development of the Ukrainian piano concert are presented: the end of the 20s-30s of the XX century – the origin and formation, the 40-60s – the development period, the 80-90s – the heyday of the concert genre. The best examples of this genre in the works of domestic composers of the past and the present are analyzed, namely, piano concerts by L. Revutsky, M. Skorik, V. Ptushkin. It has been proved that the positive qualities of the piano concerto No. 2 of L. Revutsky consist in the organic development of Ukrainian classical traditions, in the deep embodiment of elevated, cheerful moods, lyrical-excited pathetics, and strong-willed images. The piano concerto No. 1 by M. Skorik is characterized by an artistic-figurative emotionality combined with brilliant virtuosity and is designed for vivid external effects. Marked by neoclassical style, M. Skorik’s concert is built on the free competition of a virtuoso pianist with an orchestra and refers to the type of concerts with relatively equal parts of solo and orchestra. When performing the interpretation of the first part of the piano concert of V. Ptushkin, the main attention is paid to the nature of the performance of the main themes, namely the contrast and dialogue between them. It was found out that acquaintance of students-pianists in the instrumental performance classes with the genre of the Ukrainian piano concerto expands the knowledge of future music art teachers in developing this genre in our country. Processing the best examples of piano concerts by composers of the past and the present develops a sense of ensemble playing among students, influences timbre hearing, introduces composers' innovations in the fields of style, musical language, means of shaping, as well as a wide emotional palette of musical images. The concerts focused on the functions of a soloist and orchestra, the artistic content of works, shaping, composer innovations in the field of musical language.
APA, Harvard, Vancouver, ISO, and other styles
38

Auiler, J. F., K. Liu, J. M. Lynch, and C. K. Gelotte. "Effect of Food on Early Drug Exposure from Extended-Release Stimulants: Results from the Concerta®, Adderall XR™ Food Evaluation (CAFÉ) Study." Current Medical Research and Opinion 18, no. 5 (January 2002): 311–16. http://dx.doi.org/10.1185/030079902125000840.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Blumer, Sigalit, Rula Shehadi Khoury, and Benjamin Peretz. "The Prevalence of ADHD Patients among Pediatric Dentists in Israel and Knowledge of Dental and Behavioral Aspects of Treating Them." Journal of Clinical Pediatric Dentistry 42, no. 3 (January 1, 2018): 212–16. http://dx.doi.org/10.17796/1053-4628-42.3.8.

Full text
Abstract:
Objective: There are no clear guidelines for managing the dental treatment of children with attention deficit hyperactivity disorder (ADHD). The use of sedation in combination with chronic ADHD medication use is also not well defined. This study surveyed the prevalence of ADHD children, management techniques and knowledge of pharmacologic therapies of these children among Israeli dentists. Study Design: A specially designed questionnaire was distributed to all Israeli dentists attending a national conference in 2016. Results: Of the 160 dentists who attended the conference, 96 completed the survey (60% response rate), and they included 46 (51%) pediatric dental specialists and 50 (49%) general dental practitioners. The medications Ritalin and Concerta were most familiar to the respondents (98.9%). Eighty-seven (91.1%) of the practitioners responded that their ADHD patients take their usual doses of any drug for treating ADHD symptoms, regardless of whether or not the dentists intended to use sedatives. The practitioners invented their own behavior management techniques with varying degrees of success. Conclusions: There are no specific guidelines for the most effective pharmacologic protocol (co-administration of ADHD drugs and dental sedatives) or behavior management techniques for the provision of optimal dental care to children with ADHD.
APA, Harvard, Vancouver, ISO, and other styles
40

Thompson, Anne E., Saeed A. Nazir, Mohammed J. Abbas, and Julie Clarke. "Switching from immediate- to sustained-release psychostimulants in routine treatment of children with attention-deficit hyperactivity disorder." Psychiatric Bulletin 30, no. 7 (July 2006): 247–50. http://dx.doi.org/10.1192/pb.30.7.247.

Full text
Abstract:
Aims and MethodTo investigate the effectiveness of switching children with attention-deficit hyperactivity disorder (ADHD) from immediate- to sustained-release psychostimulants (Concerta XL, a novel methylphenidate hydro-chloride) and to examine factors associated with treatment success or failure. This was a retrospective study of all such children known to four clinicians in Lincolnshire, over a 2-year period. The initial response to treatment and the response to slow-release psychostimulant as judged by the clinicians were recorded. Data were analysed using the Statistical Package for the Social Sciences version 12.ResultsOf the children who were switched (n=97) and on whom clinical judgement was available (n=92), a statistically significant number (32%) responded poorly (P<0.001). In 26 out of the 97 patients, the switching was considered as a treatment failure and they were switched back to the original immediate-release stimulants. There was no significant-difference with possible confounding variables between children who responded well and those who responded poorly after switching to sustained-release drug.Clinical ImplicationsIn a real-life clinical situation there is a significant failure rate when a child with ADHD is switched from an immediate- to sustained-release psychostimulant. Further studies are needed.
APA, Harvard, Vancouver, ISO, and other styles
41

Drisdale III, John K., Monica G. Thornhill, and Alexandre R. Vieira. "Specific Central Nervous System Medications Are Associated with Temporomandibular Joint Symptoms." International Journal of Dentistry 2017 (2017): 1–5. http://dx.doi.org/10.1155/2017/1026834.

Full text
Abstract:
Aims. There is evidence of association between bruxism and the increasingly common central nervous system stimulants prescribed for attention deficit hyperactivity disorder (ADHD), as well as the selective serotonin reuptake inhibitors (SSRIs) often prescribed for depression or anxiety. However, the evidence is not clear on whether these medications inducing bruxism are directly associated with temporomandibular joint disorder (TMD). The aim of this work is to evaluate whether these medications are associated with TMD symptoms.Methods. Medical history and participant data were obtained for 469 patients from the University of Pittsburgh School of Dental Medicine, Dental Registry and DNA Repository, dating back to 2006. The chi-square test was used to determine any statistically significant associations.Results. There were no statistically significant associations between ADHD stimulant medications or SSRIs and reported TMD symptoms. However, there were significant differences seen between specific brands of medications and reported TMD symptoms. Individuals prescribed methylphenidate (Concerta) were less likely to report temporomandibular joint discomfort (p=0.01). Conversely, individuals prescribed citalopram (Celexa) were more likely to report temporomandibular joint discomfort (p=0.04).Conclusion. Signs and symptoms of temporomandibular joint dysfunction may be influenced by the use of certain medications prescribed for depression or attention deficit hyperactive disorder.
APA, Harvard, Vancouver, ISO, and other styles
42

Carneiro, Nathalia Bufaiçal Rassi, Daniela Alves dos Santos Gomes, and Leonardo Luiz Borges. "Perfil de uso de metilfenidato e correlatos entre estudantes de medicina." Revista Eletrônica Acervo Saúde 13, no. 2 (February 2, 2021): e5419. http://dx.doi.org/10.25248/reas.e5419.2021.

Full text
Abstract:
Objetivo: Observar o perfil de uso de metilfenidato e correlatos (MFC) entre estudantes de medicina e avaliar variáveis relacionadas a qualidade do sono e prática de atividade física. Métodos: Foi realizado um estudo transversal com 180 estudantes de medicina da PUC Goiás via formulário online em maio de 2020. Para análise dos dados foram empregados os testes do X2 e teste exato de Fisher, utilizando o software Past versão 4.03. Resultados: A prevalência do uso de MFC foi de 23,3%, sendo 38,9% (n=16) do sexo masculino e 61,9% (n=26) do sexo feminino. Observou-se que 57,1% (n=24) tiveram diagnóstico médico com equivalente prescrição de algum dos fármacos, enquanto 42,9% (n=18) fizeram uso não prescrito. Os medicamentos comerciais citados foram: Ritalina®, Venvanse®, Concerta® e Adderal®. Os principais efeitos adversos relatados foram insônia (62,1%), taquicardia (58,6%), ansiedade (51,7%), alteração do apetite (51,7%), estresse (41,4%), tremores (41,4%), boca seca (34,5%) e abstinência (17,2%). Conclusão: Conclui-se que o uso de psicoestimulantes cerebrais sem prescrição médica foi elevado. Devido as reações adversas desses fármacos, existe risco à saúde dos estudantes que fazem seu uso.
APA, Harvard, Vancouver, ISO, and other styles
43

González, Mario A., James E. Polli, and Jill A. Morgan. "Comments on Effect of Food on Early Drug Exposure from Extended-release Stimulants: Results from the Concerta®, Adderall XR® Food Evaluation Study." Current Medical Research and Opinion 18, no. 7 (January 2002): vii—x. http://dx.doi.org/10.1185/030079902125001218.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Nikolic, Olivera. "Ivan Jevtic’s musical universe at a crossroads of traditional and new music expression. Tendencies of changes on the example of selected works of the concert genre." Muzikologija, no. 23 (2017): 219–37. http://dx.doi.org/10.2298/muz1723217n.

Full text
Abstract:
Our interest in the position and significance of the concert music of Ivan Jevtic in the development of this genre in the Serbian music of the second half of the 20th century is based on several facts. Judging from the number of concerts and the variety of their stylistic, aesthetic, technical, expressive and historical qualities, Jevtic comes across as a composer who was the pioneer of several particular and general tendencies in the development of Serbian concert music, especially when we have the following in mind: his relationship to the musical heritage; his aspirations to master new contemporary tendencies; the time of general stylistic turmoil; compositional techniques etc. The comparative analysis of three concerts: Concerto for Tuba, Cello Symphony and Concerto for Viola points to the basic elements of traditional heritage, his reshaping of this heritage, as well as the elements of modern musical expression in the works of this composer. The analyzed paths of a part of his entire oeuvre do not exemplify the complete development of the concert genre in the Serbian music of the second half of the 20th century but, alongside with other important aspects such as historical, aesthetic, technical etc. they assist us in a better understanding of the tendencies in the development of this genre in Serbia, but also of the tendencies in Serbian music after 1945.
APA, Harvard, Vancouver, ISO, and other styles
45

Cada, Dennis J. "Questions and Answers from the F.I.X.;• Midazolam (Versed) Continuous Infusion;• High-Dose Concerta;• Noni Juice (Morinda Citrifolia) for Arthritis;• High-Dose Oxytocin;• Drotrecogin alfa (Zovant)." Hospital Pharmacy 36, no. 5 (May 2001): 503–7. http://dx.doi.org/10.1177/001857870103600506.

Full text
Abstract:
The Formulary Information Exchange (The F.I.X.) is an online drug information service available to subscribers of The Formulary Monograph Service or you may log on through drugfacts.com. In this column, we present samples of recent dialog on The F.I.X. If you would like more information on The Formulary Monograph Service or The F.I.X., please call 800-322-4349.
APA, Harvard, Vancouver, ISO, and other styles
46

Lopez, Frank, Raul Silva, Linda Pestreich, and Rafael Muniz. "Comparative Efficacy of Two Once Daily Methylphenidate Formulations (Ritalin?? LA???1 and Concerta??) and Placebo in Children with Attention Deficit Hyperactivity Disorder Across the School Day." Pediatric Drugs 5, no. 8 (2003): 545–55. http://dx.doi.org/10.2165/00148581-200305080-00005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Griesinger, David. "Clarity, Cocktails, and Concerts: Listening in Concert Halls." Acoustics Today 7, no. 1 (January 2011): 15–23. http://dx.doi.org/10.1121/1.3576191.

Full text
APA, Harvard, Vancouver, ISO, and other styles
48

Heger, Steffen, Götz-Erik Trott, Michael Meusers, Eberhard Schulz, Aribert Rothenberger, Klaus Rettig, Rossella Medori, Andreas Schreiner, and Helmut Remschmidt als Vertreter der deutsc. "Umstellung von einem unretardierten auf ein retardiertes Methylphenidatpräparat: Eine multizentrische, offene Studie an Kindern mit ADHS." Zeitschrift für Kinder- und Jugendpsychiatrie und Psychotherapie 34, no. 4 (July 2006): 257–65. http://dx.doi.org/10.1024/1422-4917.34.4.257.

Full text
Abstract:
Zusammenfassung: Fragestellung: Untersuchung der Wirksamkeit und Verträglichkeit einer Umstellung auf OROS®-Methylphenidat (OROS®-MPH, Concerta®) bei Kindern und Jugendlichen mit ADHS. Methodik: Prospektive, multizentrische, offene Studie über 3 Wochen mit 213 Kinder mit ADHS im Alter von 6 - 16 Jahren, die von einem kurzwirksamen MPH-Präparat auf OROS®-MPH einmal täglich in flexibler Dosierung umgestellt wurden. Primäre Studienendpunkte waren Veränderungen der klinischen Symptome, erhoben mittels der Subskala Unaufmerksamkeit/Hyperaktivität der IOWA Conners Rating Scale und die Beurteilung der globalen Wirksamkeit durch Eltern und Lehrer. Sicherheit und Verträglichkeit wurden durch Erfassung von unerwünschten Ereignissen ermittelt. Die Entwicklung von Gewicht, sowie Veränderungen von Schlafqualität und Appetit wurden beobachtet. Ergebnisse: Die Umstellung auf OROS®-MPH einmal täglich führte zu einer signifikant besseren Kontrolle der ADHS-Symptome in der Elterneinschätzung. Dagegen zeigten sich nach Beurteilung der Lehrer keine signifikanten Veränderungen zur vorherigen Therapie. Die globale Wirksamkeit wurde von den Lehrern in 55%, von den Eltern in 79% und von den Prüfärzten in 77% der Fälle als «gut» oder «hervorragend» angesehen. OROS®-MPH wurde gut vertragen. Häufigste unerwünschte Ereignisse (UE) waren Kopfschmerzen (8,9%) und Rhinopharyngitis (7,0%). Unerwartete UE wurden nicht beobachtet. Schlussfolgerungen: Die Umstellung von ADHS-Patienten, die zuvor stabil auf IR-MPH eingestellt waren, auf OROS®-MPH einmal täglich führte zu einer signifikanten Verbesserung der ADHS-Symptome nach Einschätzung der Eltern. In der Schule zeigte OROS®-MPH eine vergleichbare Wirkung wie die vorher durchgeführte Therapie.
APA, Harvard, Vancouver, ISO, and other styles
49

Vazquez, V. "PMH13 COST-EFFECTIVENESS ANALYSIS OF SINGLE-DOSE EXTENDED RELEASE METHYLPHENIDATE (CONCERTA®) VS. ATOMOXETINE AND SHORT-ACTION METHYLPHENIDATE, FOR THE MANAGEMENT OF ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY IN MEXICO." Value in Health 10, no. 3 (May 2007): A75. http://dx.doi.org/10.1016/s1098-3015(10)68766-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Lima, C., D. Rodrigues, M. Silva, and S. Rego. "The Impact of Psychopedagogical Intervention on Quality of Life in Adolescents with Attention Deficit Hyperactivity Disorder (ADHD) Treated with Psychostimulant Medication." European Psychiatry 41, S1 (April 2017): S215. http://dx.doi.org/10.1016/j.eurpsy.2017.01.2192.

Full text
Abstract:
Several studies have shown that ADHD has a significant negative impact on multiple domains of quality of life of children and adolescents, particularly in terms of behavioral, emotional and psychosocial quality of life. The psychopedagogical intervention can be therapeutic, preventive and promote educational inclusion. Moreover, it aims to address the learning process, how it is developed and how the individual relates himself to learning, both in the cognitive, social and emotional domains. Our purpose was to understand whether the psychopedagogical intervention influences the quality of life of adolescents with ADHD considering their pharmacological plans. The aim of this study was to evaluate the impact of a psychopedagogical intervention on quality of life of a sample of adolescents with ADHD taking into account their pharmacological plans (rubifen, ritalin, and concerta). We used quantitative and qualitative assessment measures: the KIDSCREEN-10, to measure the quality of life of these adolescents, and a semi-structured interview to assess the impact of a psychopedagogical intervention in the lives of these adolescents and their parents, respectively. The results showed that psychopedagogical intervention has a positive impact on the quality of life of adolescents with ADHD, as well as in the family dynamics. Due to the demands of school work (homework) and their negative impact on the family dynamics and consequently in the quality of life, the results corroborate the relevance of a psychopedagogical intervention to improve these areas. Thus, it appears that this type of intervention is very useful for adolescents with ADHD.Disclosure of interestThe authors have not supplied their declaration of competing interest.
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Concerta' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography